NYSE:GI EndoChoice (GI) Stock Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free GI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$8.00▼$8.0050-Day Range N/A52-Week Range$3.64▼$9.47VolumeN/AAverage Volume131,115 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get EndoChoice alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. About EndoChoice Stock (NYSE:GI)EndoChoice Holdings, Inc. is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems. The Company's products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The Company's imaging products include Fuse system, EndoCart, and Endoscope repair and maintenance. The Company's single-use therapeutic devices include Neptune injection needle, Boa polypectomy snare, Rescue retrieval devices, Blox bite block, TrapEase polyp traps, Hydra irrigation system, EndoGlide+, Compliance EndoKit, SafeStart, EndoKit, CinchPad and GI pathology. The Company serves over 2,500 GI departments that perform endoscopic procedures.Read More Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. GI Stock News HeadlinesMay 5, 2023 | marketwatch.comFlexible Endoscopes Market Growth, Business Overview 2023, and Forecast to 2029 | Olympus, Fujifilm, HOYAApril 27, 2023 | marketwatch.comEndoscopic Accessories Market Business Report [2023-2030]April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. April 24, 2023 | marketwatch.comEndoscopic Accessories Market Global Analysis 2023-2030March 29, 2023 | marketwatch.comEndoscopic Accessories Market New Ready Report Analysis 2028March 18, 2023 | health.usnews.comBest Children's Hospitals for Gastroenterology & GI SurgeryFebruary 27, 2023 | marketwatch.com2023 Flexible Endoscopes Market Largest Share and Growth Potential by 2026 | 94 PagesFebruary 21, 2023 | marketwatch.comEndoscopic Accessories Market International Business Analysis, Development Outlook and Regional Strategies 2028April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. February 3, 2023 | marketwatch.comGastroenterology Market 2023 Production, Revenue, Growth Rate, Price and Gross Margin, Opportunities and Forecast 2028January 12, 2023 | benzinga.comModifyHealth Secures $10 Million Series B Investment to Fuel Growing Demand for Its Medically Tailored Meals and Food as Medicine PlatformJanuary 10, 2023 | bizjournals.comAlpharetta dietary startup ModifyHealth gets largest raise to dateDecember 19, 2022 | marketwatch.comGastroenterology Market Statistics 2023 : Industry Demand, Prominent Players Strategies, Size, SWOT Analysis and Forecast 2028October 27, 2022 | health.usnews.comBest Hospitals for Gastroenterology & GI SurgeryOctober 25, 2022 | marketwatch.comEndoscopic Accessories Market Is Likely to Experience a Massive Growth in Near Future - Report Spread across 97 PagesAugust 26, 2022 | marketwatch.comFlexible Endoscopes Market Is Likely to Experience a Strong Growth During 2022-2028 with Top Countries Data | 90 Pages ReportAugust 25, 2022 | marketwatch.comFlexible Endoscopes Market 2022 Sales, Revenue, Analysis, Dynamics, Share, Future Trends, Emerging Growth Factors till 2026May 25, 2022 | marketwatch.comEndoscopic Accessories Market Share, Top Key Players, Industry Size, Growth Prospects, Value Chain, Type, Business Strategy and Forecast to 2027March 18, 2022 | finance.yahoo.comDisposable Endoscopes Market Size Worth Around US$ 10.4 Bn by 2030February 22, 2022 | fool.comEndoChoice Holdings, Inc.(GI)See More Headlines Receive GI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EndoChoice and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/04/2016Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:GI CUSIPN/A CIK1623919 Webwww.endochoice.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report GI Stock Analysis - Frequently Asked Questions How were EndoChoice's earnings last quarter? EndoChoice Holdings Inc (NYSE:GI) released its quarterly earnings results on Wednesday, May, 4th. The medical equipment provider reported ($0.68) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.13. The medical equipment provider earned $18.46 million during the quarter, compared to the consensus estimate of $18.34 million. The business's quarterly revenue was up 10.2% compared to the same quarter last year. During the same period last year, the firm earned ($1.00) earnings per share. What other stocks do shareholders of EndoChoice own? Based on aggregate information from My MarketBeat watchlists, some companies that other EndoChoice investors own include Cognyte Software (CGNT), Coeur Mining (CDE), Calithera Biosciences (CALA), DarioHealth (DRIO), Foresight Energy (FELP), (FMSA) (FMSA), Gran Tierra Energy (GTE), NewAge (NBEV), Nam Tai Property (NTP) and On Track Innovations (OTIV). When did EndoChoice IPO? EndoChoice (GI) raised $101 million in an initial public offering on Friday, June 5th 2015. The company issued 6,300,000 shares at $15.00-$17.00 per share. J.P. Morgan, BofA Merrill Lynch, William Blair and Stifel acted as the underwriters for the IPO. This page (NYSE:GI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EndoChoice Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
